BDX
Pharmaceuticals, Biotechnology & Life Sciences
Bcal Diagnostics
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 6 June 2025
- Reported shorts
- 304
- Shares on issue
- 365.968M
Bcal Diagnostics (BDX) short interest history
Short interest chart
Toggle series, zoom, and compare · ASIC daily, T+4BDX Short Interest History
- 30-day change
- -0.01pp
- 90-day change
- -0.12pp
- 1-year change
- -0.20pp
- All-time high
- 0.36% (July 2021)
- All-time low
- 0.00% (June 2025)
Is BDX heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has BDX's short interest changed recently?
Over the past 30 days Bcal Diagnostics's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest BDX's short interest has been?
Since 2021, Bcal Diagnostics's short interest peaked at 0.36% in July 2021 and bottomed at 0.00% in June 2025.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2021. See our methodology.